✦ LIBER ✦

Protein phosphatase 2A: A novel pharmaceutical target for the treatment of Alzheimer's disease

✍ Scribed by Stock, Jeffry B.

Book ID: 122962652
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 44 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.04.512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protein phosphatase 2A: a target for ant

Protein phosphatase 2A: a target for anticancer therapy

✍ Perrotti, Danilo; Neviani, Paolo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 288 KB

A protein phosphatase-2A-based etiopatho

A protein phosphatase-2A-based etiopathogenic mechanism of Alzheimer's disease

✍ Khalid Iqbal; Xiaochuan Wang; Julie Blanchard; Inge Grundke-Iqbal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 40 KB

The protein phosphatase 2A represents a

The protein phosphatase 2A represents a novel cellular target for hepatitis C virus NS5A protein

✍ Urania Georgopoulou; Panagiota Tsitoura; Maria Kalamvoki; Penelope Mavromara 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 634 KB

Galantamine. A novel treatment for Alzhe

Galantamine. A novel treatment for Alzheimer's disease

✍ David Greenwood 📂 Article 📅 1998 🏛 Pharmaceutical Press 🌐 English ⚖ 117 KB

P2-315: A novel biotherapy for the treat

P2-315: A novel biotherapy for the treatment of Alzheimer's disease

✍ Yu, Jin; Gattoni-Celli, Sebastiano; Zhu, Hong; Kindy, Mark S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

β-secretase as a target for the treatmen

β-secretase as a target for the treatment of Alzheimer's disease

✍ Martin Citron 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 1 views

## Abstract Finding inhibitors of the first step of the amyloid cascade, Aβ~42~ generation, is a major goal of Alzheimer's disease drug development. Two target protease activities, β‐and γ‐secretase, were detected more than 10 years ago but progress in this area has been slow because the enzymes we